The National Pharmaceuticals Pricing Policy 2011 presently seeks to limit itself to the central objective of promulgating the principles for pricing of Essential Drugs as laid down in the “National List of Essential Medicines ‐ 2011” as declared
by the Ministry of Health and Family Welfare, Government of India vide communication No.12‐01/essential medicines/08‐DC/DFQC, dated 8th June, 2011. Other related and required steps for promoting growth of the
Pharmaceutical Industry as well as development of new drugs including patented drugs, along with institutional mechanisms for better access to healthcare in the context of availability of medicines in general, would be formulated separately and thereafter adopted by the Government after due consultative process.